CLAREMONT, CA 鈥� In a collaborative environment filled with networking opportunities, 蜜桃直播 (蜜桃直播) hosted the Industry Insights Bioprocessing Conference 鈥淏ioprocessing for Advanced Therapeutic Medicinal Products鈥� along with 蜜桃直播鈥檚 Annual Meeting on November 7-8.
蜜桃直播 hosted the two-day event in collaboration with (IPS) and .
鈥淲e thoroughly enjoyed sharing knowledge with industry experts and leading suppliers who are on the cutting edge within the field of bioprocessing,鈥� said , George B. and Joy Rathmann Professor and Director of the Amgen Bioprocessing Center at 蜜桃直播.
鈥淚t was a great opportunity to showcase the tremendous work of our master鈥檚 and PhD students.鈥�
Mary Malloney of Juno Therapeutics, Joe Newell from Atara Biotherapeutics, and Rajesh Krishnan of Oncternal shared presentations about bioprocessing and engineering processes in the area of advanced therapeutic medicinal products.
This conference was chaired by Dr. Vic Vinci, Vice President of Product Development at Catalent Biologics. 蜜桃直播 students delivered insightful presentations on stem cell research, considerations for drug product development for cell therapy products, and other current research activities.
David Kent, a second-year student, was one of the presenters on Nov. 8. He first came to 蜜桃直播 through the Bioprocessing Summer Undergraduate Internship Training and Education (BSUITE) program, and stayed on to pursue his MEng degree.
鈥淚 want to impact patient lives and understand the current limitations of getting affordable life-changing medicines to patients around the world,鈥� said Kent. 鈥淚 was introduced to cell therapy during BSUITE, and this past summer I was able to take my first step into this world during an internship at Amgen. I am eager to take my continued education back to industry to start helping patient lives.鈥�